Health Care Access for Asylum Seekers in Brittany : Description, Associated Factors and Levers of Improvement (ACCEDAB)

November 26, 2018 updated by: Rennes University Hospital

The main objective of this research is to study the logics and the associated factors with asylum seekers use of dedicated health structures.

This objective aims to address major concerns related to the entry and continued participation in the health care system of asylum seekers, including the medical and social dimensions.

It aims to produce, then analyze and disseminate data on the factors associated with seeking asylum seekers to optimize the care of migrants in the French health system

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Rennes, France, 35000
        • Recruiting
        • COALLIA - Plateforme d'accueil des demandeurs d'asile
        • Contact:
          • Sandra Silver
          • Phone Number: +33 2 99 51 86 28
      • Rennes, France, 35033
        • Active, not recruiting
        • CHU de Rennes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult asylum seekers who have applied for asylum in the prefecture of Brittany

Description

Inclusion Criteria:

- Adult asylum seekers who have applied for asylum in the prefecture of Brittany from May 22, 2018 to May 21, 2019 (or one year after obtaining authorization from the CCTIRS and the CNIL).

Exclusion Criteria:

  • Migrants not asylum seekers (with tourist visa, migrants of the European Union (foreign nationality and not membership in the Schengen area), migrants arriving in a family reunification, migrant in irregular situation).
  • Minor : unaccompanied foreign minor or with their family
  • Incapacity of a person to consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Use of health care structure
Time Frame: 6 months
Factors associated with the use or non-use of dedicated health facilities will be the individual (sociodemographic, migration), organizational (access to rights, characteristics of the organization of dedicated structures) and the environment characteristics reported by asylum seekers having or not having recourse to the dedicated health structures.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Rennes University Hospital

Investigators

  • Principal Investigator: Pascal Jarno, MD, Rennes University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 22, 2018

Primary Completion (Actual)

May 22, 2018

Study Completion (Anticipated)

November 22, 2019

Study Registration Dates

First Submitted

November 22, 2018

First Submitted That Met QC Criteria

November 26, 2018

First Posted (Actual)

November 27, 2018

Study Record Updates

Last Update Posted (Actual)

November 27, 2018

Last Update Submitted That Met QC Criteria

November 26, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 35RC16_9852_ACCEDAB

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on access to healthcare

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe